Industry Symposium: Cases and Conversations™: Uniting Heart and Kidney Care: Optimizing Outcomes in Cardio-Kidney-Metabolic Disorders Supported by Boehringer Ingelheim
4:30 PM - 5:30 PM PT
Industry Symposium: Cases and Conversations™: Uniting Heart and Kidney Care: Optimizing Outcomes in Cardio-Kidney-Metabolic Disorders Supported by Boehringer Ingelheim
Location: Sapphire 410
6:00 PM - 8:00 PM PT
AHA Dinner Presentation
6:00 PM - 8:00 PM PT
American Heart Association Dinner Symposium: Get With The Guidelines® Welcome Exchange: Innovation in Heart Failure Care
Location: Aqua Salon EF
Wednesday, June 24, 2026
7:30 AM - 9:00 AM PT
Breakfast Symposium: Winning Strategies for Managing Transthyretin Cardiac Amyloidosis Supported by Alnylam
7:30 AM - 9:00 AM PT
CE Breakfast Symposium: Winning Strategies for Managing Transthyretin Cardiac Amyloidosis Supported by an Independent Educational Grant from Alnylam
W7 - General Session: Maintaining RAAS Inhibition and Managing Hyperkalemia: Expert Insights into Best HF Patient Care Supported by an Independent Educational Grant from AstraZeneca
4:35 PM - 5:35 PM PT
W7 - General Session: Maintaining RAAS Inhibition and Managing Hyperkalemia: Expert Insights into Best HF Patient Care Supported by an Independent Educational Grant from AstraZeneca
Location: Sapphire Ballroom AB
Faculty: Stephen J. Greene, MD – Duke Clinical Research Institute, Duke University School of Medicine
W8 - Research Poster #1: Can Inpatient Heart Failure Nurses Drive Early work up of aTTR Cardiac Amyloidosis with the Use of a Red Flag Screening Tool in the Electronic Health Record?
W8 - Research Poster #6: Where there's a will, there's a way: The relationship among will to live, hope, illness representations, and heart failure self-care
W8 - Best Practice Poster #1: Successful Use of Novel, Non-Invasive Remote Monitoring Technology for Management of a Heart Failure Patient: A Sensinel TM CPM System Case Study
W8 - Best Practice Poster #3: Transforming Documentation to Drive Change: Leveraging Epic Smart Phrases to Improve ARNI Utilization in Heart Failure Care
W8 - Best Practice Poster #6: Implementing a Standardized Blast-Page Workflow to Reduce Emergency Department Throughput Times for LVAD Patients: A Five-Year Quality Improvement Experience
W8 - Best Practice Poster #9: Bridging the Gap: A Best Practice Model for Reducing Heart Failure Readmissions Through Inpatient-Outpatient Collaboration
W8 - Industry Poster #1: Acoramidis Mitigates the Rise in N-terminal Pro-B-type Natriuretic Peptide Levels Observed With Placebo in Patients With Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM
W8 - Industry Poster #2: Association Between Early Increase in Serum Transthyretin With Acoramidis and Long-Term Effects on Heart Failure-Related Health Status in Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM
W8 - Industry Poster #3: Long‑Term Benefits With Acoramidis on Serum Transthyretin Concentrations and Kansas City Cardiomyopathy Questionnaire-Overall Summary Score in Patients With Transthyretin Amyloid Cardiomyopathy
Location: Sapphire West Foyer
Poster Presenter: Kellie Walsh, MSN, APRN, FNP-BC – Oregon Health & Science University, OHSU Knight Cardiovascular Institute
5:40 PM - 6:40 PM PT
W8 - Industry Poster #4: Long-Term Clinical Benefits of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy and Early Heart Failure Severity, and Survival Benefits Regardless of Atrial Fibrillation Status
W8 - Industry Poster #6:Pivotal trial: Design and rationale for a remote patient-autonomous peripheral edema monitoring device to reduce hospital readmissions
Breakfast Symposium: A New Treatment for Obstructive Hypertrophic Cardiomyopathy (oHCM): Clinical Perspectives and Practical Uses Supported by Cytokinetics
Product Theater: Successful Use of Novel, Non-Invasive Remote Monitoring Technology for Management of a Heart Failure Patient: A SensinelTM CPM System case Study Supported by Analog Devices
Location: Sapphire Ballroom CD
10:30 AM - 11:15 AM PT
T3 - General Session: New Opportunities with Mineralocorticoid Receptor Antagonists to Improve Outcomes in Heart Failure Supported by an Independent Grant from Bayer
10:30 AM - 11:15 AM PT
T3 - General Session: New Opportunities with Mineralocorticoid Receptor Antagonists to Improve Outcomes in Heart Failure Supported by an Independent Grant from Bayer
Location: Sapphire Ballroom AB
Faculty: Ankeet Bhatt, MD, MBA, ScM – Assistant Professor, Kaiser Permanente Bernard J. Tyson School of Medicine
Product Theater: To Lead or Not to Lead - That is the Question: Implant Experiences, Tips and Patient Selection Consideration ILR/Leadless/EVICDSupported by Medtronic
Moderator: Andrea Wallace, NP – Baptist Memorial Hospital/ Stern Cardiovascular Center
CE: 1
12:15 PM - 1:30 PM PT
CE Lunch Symposium: Advancing Heart Failure Care: Integrating CCM Therapy Beyond GDMT Supported by an Independent Educational Grant from Impulse Dynamics
12:15 PM - 1:30 PM PT
CE Lunch Symposium: Advancing Heart Failure Care: Integrating CCM Therapy Beyond GDMT Supported by an Independent Educational Grant from Impulse Dynamics
F9 - Implementing a Standardized Blast-Page Workflow to Reduce Emergency Department Throughput Times for LVAD Patients: A Five-Year Quality Improvement Experience
Dinner Symposium: Evaluating How Clinical Outcomes for CAMZYOS® Inform the Treatment Journey in Patients With Symptomatic NYHA Class II-III Obstructive HCM Supported by Bristol Myers Squibb
5:45 PM - 6:45 PM PT
Dinner Symposium: Evaluating How Clinical Outcomes for CAMZYOS® Inform the Treatment Journey in Patients With Symptomatic NYHA Class II-III Obstructive HCM Supported by Bristol Myers Squibb
Location: Aqua Salon EF
Saturday, June 27, 2026
7:00 AM - 8:00 AM PT
Breakfast Symposium Supported by Boehringer Ingelheim
7:00 AM - 8:00 AM PT
CE Breakfast Symposium: Connecting the Dots in CKM Care: Empowering Nurses to Drive Cardio-Kidney-Metabolic Outcomes Supported by Boehringer Ingelheim
Location: Aqua Salon EF
7:00 AM - 2:00 PM PT
Registration Hours
7:00 AM - 2:00 PM PT
Registration Hours
Location: Sapphire North Foyer
8:00 AM - 5:00 PM PT
Pharmacology Workshop
8:00 AM - 5:00 PM PT
Pharmacology Workshop
Location: Sapphire 410
8:00 AM - 9:30 AM PT
P1 - The Future of Pharmacological Management of patients with HF